Life sciences news
-
Jyseleca®▼(filgotinib) approved in the European Union for the treatment of ulcerative colitis
Monday November 15th 2021
Read more
-
Biotalys’ first biocontrol Evoca™ demonstrated to be excellent new tool for growers in 2021 independent field trials
Monday November 15th 2021
Read more
-
OXURION NV - First patient dosed in Part B of Phase 2 KALAHARI study evaluating multiple administrations of THR-149 versus aflibercept for treatment of Diabetic Macular Edema (DME)
Monday November 15th 2021
Read more
-
GSK and imec to collaborate on disruptive innovation in pharma
Tuesday November 9th 2021
Read more
-
reMYND and the US NINDS Epilepsy Therapy Screening Program (ETSP) begin collaboration on epilepsy program
Monday November 8th 2021
Read more
-
Agomab Therapeutics to acquire Origo Biopharma
Thursday October 28th 2021
Read more
-
Thirona closes financing round with HERAN Partners and Borski Fund
Thursday October 28th 2021
Read more
-
reMYND’s ReS19-T program, managing calcium homeostasis for Alzheimer’s, has moved to MAD phase after demonstrating strong safety in SAD phase
Thursday October 21st 2021
Read more
-
Become a flanders.bio member
Your news here?
-
Mithra announces Estelle® launch in Belgium
Thursday October 21st 2021
Read more
-
Biotalys awarded multi-year grant to develop new biological solutions for cowpea and other legumes
Wednesday October 20th 2021
Read more
-
The Board of Directors confirms Leon Van Rompay as Mithra’s CEO
Monday October 18th 2021
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator
